BCAL Diagnostics Limited (AU:BDX)
ASX:BDX
Australian Market
Holding AU:BDX?
Track your performance easily

BCAL Diagnostics Limited (BDX) Financial Statements

6 Followers

BCAL Diagnostics Limited Financial Overview

BCAL Diagnostics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.026; its P/E ratio is -4.04; BCAL Diagnostics Limited is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total Revenue-
Gross Profit-
EBIT-
EBITDA-
Net Income Common Stockholders-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 9.57M
Total AssetsAU$ 10.59M
Total DebtAU$ 0.00
Net DebtAU$ -9.57M
Total LiabilitiesAU$ 950.42K
Stockholders EquityAU$ 9.64M
Cash Flow-
Free Cash Flow-
Operating Cash Flow-
Investing Cash Flow-
Financing Cash Flow-
Currency in AUD

BCAL Diagnostics Limited Earnings and Revenue History

BCAL Diagnostics Limited Debt to Assets

BCAL Diagnostics Limited Cash Flow

BCAL Diagnostics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis